Agilent Technologies has launched GeneSpring FX 10.0, the latest version of its flagship gene expression bioinformatics platform, now offering tools for systems-level data interpretation and pathway analysis. This will enable scientists to attain a new level of insight into the underlying mechanism of disease or biological process.
As systems-level studies become more prevalent in genomics research, GeneSpring GX 10.0 adds visualisation and analysis tools for applications including alternative splicing, miRNA expression and real-time PCR. To get more insight into the underlying mechanism of disease, GeneSpring now has powerful pathway analysis capabilities. By providing a database of gene product interactions, scientists can build biological interaction networks from their genes of interest.
GeneSpring also provides statistical tools to detect significant changes in miRNA abundance, and integrates TargetScan miRNA gene-target information to determine the biological consequences of detected changes. Additionally, to facilitate validation of microarray experiments, GeneSpring GX 10.0 supports analysis of real-time PCR data.
To support enterprise functional genomics data-analysis needs, Agilent offers GeneSpring Workgroup, a client-server application with GeneSpring GX as the data-analysis engine providing central and secure storage for GeneSpring data and analysis results.
